Promazine
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Promazine
|
|
| Systematic (IUPAC) name | |
| N,N-dimethyl-3-(10H-phenothiazin-10-yl) propan-1-amine | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H20N2S |
| Mol. mass | 284.42 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 94% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Promazine (marketed as Sparine) is a medication that belongs to the phenothiazine class of antipsychotics. An older medication used to treat schizophrenia, its use has largely been replaced by newer agents such as olanzapine and quetiapine.
It has predominantly anticholinergic side effects, though extrapyramidal side effects are not uncommon either.
|
|||||||||||
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
